- Home
- FT vs STXS Comparison
FT vs STXS Comparison
Compare FT & STXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FT
- STXS
- Stock Information
- Founded
- FT 1988
- STXS 1990
- Country
- FT United States
- STXS United States
- Employees
- FT N/A
- STXS N/A
- Industry
- FT Trusts Except Educational Religious and Charitable
- STXS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- FT Finance
- STXS Health Care
- Exchange
- FT Nasdaq
- STXS Nasdaq
- Market Cap
- FT 185.7M
- STXS 189.8M
- IPO Year
- FT N/A
- STXS 2004
- Fundamental
- Price
- FT $7.25
- STXS $2.08
- Analyst Decision
- FT
- STXS Strong Buy
- Analyst Count
- FT 0
- STXS 2
- Target Price
- FT N/A
- STXS $4.50
- AVG Volume (30 Days)
- FT 63.0K
- STXS 422.5K
- Earning Date
- FT 01-01-0001
- STXS 03-03-2025
- Dividend Yield
- FT 7.85%
- STXS N/A
- EPS Growth
- FT N/A
- STXS N/A
- EPS
- FT N/A
- STXS N/A
- Revenue
- FT N/A
- STXS $25,143,000.00
- Revenue This Year
- FT N/A
- STXS $1.16
- Revenue Next Year
- FT N/A
- STXS $55.65
- P/E Ratio
- FT N/A
- STXS N/A
- Revenue Growth
- FT N/A
- STXS N/A
- 52 Week Low
- FT $5.97
- STXS $1.66
- 52 Week High
- FT $7.23
- STXS $3.29
- Technical
- Relative Strength Index (RSI)
- FT 36.05
- STXS 42.68
- Support Level
- FT $7.25
- STXS $2.21
- Resistance Level
- FT $7.35
- STXS $2.72
- Average True Range (ATR)
- FT 0.10
- STXS 0.16
- MACD
- FT 0.00
- STXS -0.04
- Stochastic Oscillator
- FT 57.50
- STXS 7.54
About FT Franklin Universal Trust
Franklin Universal Trust is a closed-end management investment company. Its primary investment objective is to provide high, current income consistent with the preservation of capital. Its secondary objective is the growth of income through dividend increases and capital appreciation. The fund invests in two asset classes being the high yield bonds and utility stocks.
About STXS Stereotaxis Inc.
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.